Loading...
OTCMHADV
Market cap80kUSD
Dec 24, Last price  
0.00USD
1D
0.00%
1Q
-41.18%
Jan 2017
-99.58%
IPO
-99.67%
Name

Health Advance Inc

Chart & Performance

D1W1MN
OTCM:HADV chart
P/E
P/S
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
49.96%
Rev. gr., 5y
%
Revenues
0k
0100000020,000000
Net income
-49k
L-81.82%
-68,177-109,156-86,028-72,080-67,551-29,50316,947-130,659-269,653-49,022
CFO
-12k
L-95.74%
-10,177-40,687-31,108-31,291-38,611-25,768-35,315-196,764-273,236-11,652

Profile

Health Advance Inc., a development stage company, operates as an on-line retailer of home medical products in Canada and the United States. It intends to offers aids to daily living, ambulatory, bath safety, core wound care, diabetic, enteral nutrition-feeding, home diagnostics, incontinence, orthopedic, ostomy, pain management, professional use and diagnostic, respiratory, tracheostomy care, specialty wound care, and women-infant products. The company's product portfolio would also include bed accessories, catheters, diagnostic equipment, lift chairs/geri chairs, IV supplies, needles/syringes, patient lifts and acc, personal protection products/gloves, scooters and accessories, seating/cushions, specialty medical equipment and accessories, urological/collection devices, wheelchairs accessories. It focuses on operating leadingmedicalproducts.com, an e-commerce site for the retail community and health care community. The company intends to serve health care professionals, medical distributors, and consumers. Health Advance Inc. was founded in 2010 and is based in Las Vegas, Nevada.
IPO date
May 25, 2012
Employees
3
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2024‑032023‑032022‑032021‑032016‑072015‑07
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
(49)
Tax Rate
NOPAT
49
Net income
(49)
-81.82%
(270)
106.38%
(131)
-870.99%
Dividends
Dividend yield
Proceeds from repurchase of equity
250
BB yield
Debt
Debt current
18
14
Long-term debt
254
254
235
Deferred revenue
Other long-term liabilities
Net debt
272
268
235
Cash flow
Cash from operating activities
(12)
(273)
(197)
CAPEX
Cash from investing activities
Cash from financing activities
280
196
FCF
86
(4)
(72)
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
(228)
(179)
(159)
Invested Capital
461
457
427
ROIC
10.68%
ROCE
EV
Common stock shares outstanding
185,948
185,948
160,948
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT